Efficacy of Aleo Vera Use in Prevention and Treatment of Chemotherapy-Induced Oral Mucositis in a Group of Egyptian Children with Acute Leukemia

Ain Shams University

Status: Completed

Conditions: Oral Mucositis

Treatments: Other: Second arm: Using aleovera for Prevention and Treatment of Chemotherapy-Induced Oral Mucositis

Study type: Interventional

Funder types: Other

Identifiers

NCT06757270

FDASU-EecIM 022203

Details and patient eligibility

About

evaluatation the efficacy of Aleovera in prevention and treatment of chemotherapy-induced oral mucositis in children suffering from acute leukemia in terms of appearance and severity

Enrollment: 40 patients

Sex: All

Ages: 3 to 13 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

1. Patients suffering from Acute leukemia( Acute Lymphocytic Leukemia ).
2. Patients scheduled for chemotherapy treatment.
3. Patients who range from 3 to 13 years old.
4. Patients with no history of any chemotherapy or radiotherapy. 5 -Both sexes Exclusion Criteria

1-Patients scheduled for radiotherapy treatment . 2-Existence of any signs or symptoms of oral mucositis. 3-Unwilling to participation in the study 4- Patients with any other systemic diseases or other neoplasms.

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

40 participants in 2 patient groups

Alovera experminted arm

Experimental group

Treatment:

Other: Second arm: Using aleovera for Prevention and Treatment of Chemotherapy-Induced Oral Mucositis

second group

No Intervention group